Between 1995 and 2023, diagnoses of hepatitis C infection increased among HIV-positive men who have sex with men with no history of injection drug use, particularly during the era of highly active ...

When managing patients with hepatitis C virus (HCV), initiating treatment of the infection promptly is more important than determining the severity of their liver disease with the customary ...

The product, called OraQuick HCV self-test, manufactured by OraSure Technologies, is an extension of the pre-qualified, OraQuick ® HCV Rapid Antibody Test which was initially prequalified by WHO ...

Credit: Cepheid. The Xpert HCV test delivers results in about an hour. The Food and Drug Administration (FDA) has granted marketing authorization to Xpert ® HCV, a point-of-care hepatitis C virus ...

Among 133,732 veterans with HCV, 80.1% initiated treatment and 91.6% achieved SVR. Younger veterans were less likely to initiate treatment and achieve SVR. A Department of Veterans Affairs ...

The World Health Organization currently estimates the global burden of Hepatitis C to be between 130 and 170 million people. Ideally, this figure, as well as stratifications by location ...

Hepatitis C is the leading cause of chronic liver disease and liver cancer in the world and affects an estimated 51 million people globally. Though the viral infection is easily diagnosable and ...

One major reason there hasn’t been an HCV vaccine yet is that scientists have yet to identify the proper antigen, or the part of the virus would trigger a protective immune response in the body.

A new discovery points the way toward an effective HCV vaccine. A team led by scientists at Scripps Research and the University of Amsterdam has achieved an important goal in virology: mapping ...

Low hepatitis C virus (HCV) reinfection rates were shown in patients who inject drugs (PWID) after successful treatment with direct-acting antiviral (DAA) medications, according to study findings ...

Hepatitis C in newborns may occur if the person who birthed them has acquired infection with the hepatitis C virus (HCV). This happens when an unborn child contracts the infection while in the womb.

A vaccine to protect against infection with hepatitis C could be in use within 5 years, says Professor Sir Michael Houghton, who won the Nobel Prize for Medicine and Physiology along with three ...